デフォルト表紙
市場調査レポート
商品コード
1702738

弱視の世界市場レポート 2025年

Amblyopia Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
弱視の世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

弱視の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.6%で58億4,000万米ドルに成長します。予測期間における成長の要因としては、デジタルヘルスプラットフォームの台頭、保護者向けのリソースやサポートの増加、子どもの予防医療重視の高まり、弱視に対する意識の高まり、眼科専門センターやクリニックの急増などが挙げられます。予測期間における主要動向としては、診断における技術的進歩、新しい治療法の開発、視覚発達の理解の進歩、神経可塑性の発見、新薬の開発と承認などが挙げられます。

眼科疾患の罹患率の増加は、弱視市場の今後の成長を促進すると予想されます。眼科疾患には、白内障や緑内障のような一般的な疾患から網膜色素変性症や眼腫瘍のようなまれな疾患まで、眼に影響を及ぼすさまざまな疾患が含まれます。これらの疾患の増加要因としては、スクリーン使用時間の増加、人口の高齢化、汚染などの環境要因が挙げられます。特に弱視は、脳が弱いほうの目からの入力を無視することによって眼科疾患を悪化させる可能性があり、放置すると永久的な視力障害や奥行き知覚の問題につながる可能性があります。米国疾病予防管理センター(CDC)によると、2024年1月時点で40歳以上のアメリカ人のうち340万人以上が失明または視覚障害を患っており、この数は2030年までに倍増すると予想されています。したがって、眼科疾患の有病率の上昇は、弱視市場成長の重要な促進要因となっています。

弱視市場の主要企業は、周辺視野治療を強化するために能動的周辺刺激(APS)のような技術革新に注力しています。APSは、末梢神経や組織を刺激して感覚経路を活性化する治療アプローチであり、疼痛緩和、リハビリテーション、神経症状に対する潜在的なメリットを記載しています。例えば、2024年10月、デジタル視力療法を専門とする米国の新興企業AmblyoPlayは、周辺視野欠損の治療を改善するためにAPSを導入しました。この最先端技術は、弱視(寄り目)、斜視、輻輳不全など、空間認識や視覚機能全般に影響を与える症状を対象としています。APSは、周辺視野を刺激することで、世界人口の5%に影響を及ぼす公衆衛生上の問題に対処します。AmblyoPlayは、APSをゲーミフィケーションプラットフォームに組み込み、視力療法をより魅力的で楽しいものにし、特に小児にとって、治療へのより良いアドヒアランスを促進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の弱視PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の弱視市場:成長率分析
  • 世界の弱視市場の実績:規模と成長、2019~2024年
  • 世界の弱視市場の予測:規模と成長、2024~2029年、2034年
  • 世界の弱視総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の弱視市場:疾患タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 斜視弱視
  • 屈折性弱視
  • 剥奪弱視
  • 逆弱視
  • 世界の弱視市場:診断別、実績と予測、2019~2024年、2024~2029年、2034年
  • 視力検査
  • 写真上映
  • ブルックナーテスト
  • その他
  • 世界の弱視市場:治療別、実績と予測、2019~2024年、2024~2029年、2034年
  • 眼帯
  • アトロピン点眼薬
  • 眼鏡
  • ビデオゲーム
  • その他
  • 世界の弱視市場:エンドユーザー別、実績と予測、2019~2024年、2024~2029年、2034年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 世界の弱視市場斜、視弱視のサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 先天性斜視弱視
  • 後天性斜視弱視
  • 非麻痺性斜視弱視
  • 麻痺性斜視弱視
  • 目の位置ずれの治療(眼帯、視力矯正)
  • 世界の弱視市場、屈折性弱視のサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 近視屈折弱視
  • 遠視屈折弱視
  • 乱視屈折弱視
  • 矯正レンズ(眼鏡、コンタクトレンズ)による治療
  • 世界の弱視市場、剥奪性弱視のサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 弱視白内障別
  • 眼瞼下垂(まぶたのたるみ)による弱視
  • 弱視角膜混濁から
  • 外科的介入またはパッチによる治療
  • 世界の弱視市場、逆弱視のサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 弱視視神経機能障害別
  • 不同視(不同屈折異常)に関連する弱視
  • 視力訓練または光学矯正による治療

第7章 地域別・国別分析

  • 世界の弱視市場:地域別、実績と予測、2019~2024年、2024~2029年、2034年
  • 世界の弱視市場:国別、実績と予測、2019~2024年、2024~2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 弱視市場:競合情勢
  • 弱視市場:企業プロファイル
    • Novartis AG
    • Takeda Pharmaceutical Company Limited
    • Biocon Limited
    • Astellas Pharma Inc.
    • Alcon Vision LLC

第31章 その他の大手企業と革新的企業

  • Bausch Health Companies Inc.
  • HOYA Corp.
  • UnityPoint Health
  • Integra LifeSciences
  • Wockhardt Ltd.
  • Welch Allyn
  • Heidelberg Engineering Inc.
  • Orbis International
  • Oculus Optikgerate GmbH
  • Ocutrx Vision Technologies LLC
  • AccuVision
  • Vivid Vision Inc.
  • Fresnel Prism and Lens Co.
  • RevitalVision
  • WOW Vision Therapy

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

  • 弱視市場、2029年:新たな機会を提供する国
  • 弱視市場、2029年:新たな機会を提供するセグメント
  • 弱視市場、2029年:成長戦略
    • 市場動向による戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r29392

Amblyopia, commonly referred to as lazy eye, is a condition affecting the development of vision where one eye does not achieve normal visual acuity, even with corrective eyewear such as glasses or contact lenses. Typically beginning in infancy or early childhood, amblyopia occurs due to a lack of proper coordination between the eye and the brain. As time progresses, the brain starts to favor the eye with better vision, leading to further deterioration of the weaker eye.

There are several types of amblyopia strabismus amblyopia, refractive amblyopia, deprivation amblyopia, and reverse amblyopia. Strabismus amblyopia results from misalignment of the eyes, causing a discrepancy in visual acuity between them. Diagnosis involves visual acuity tests, photo screening, Bruckner tests, and others. Treatment options include the use of eye patches, atropine drops, corrective glasses, and sometimes even therapeutic video games. Amblyopia affects diverse sectors including hospital pharmacies, retail pharmacies, and online pharmacies.

The amblyopia market research report is one of a series of new reports from The Business Research Company that provides amblyopia market statistics, including amblyopia industry global market size, regional shares, competitors with a amblyopia market share, detailed amblyopia market segments, market trends and opportunities, and any further data you may need to thrive in the amblyopia industry. This amblyopia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The amblyopia market size has grown steadily in recent years. It will grow from $4.65 billion in 2024 to $4.88 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to a rise in the incidence of ophthalmological illnesses, rise in consumer demand for affordable glasses, the prevalence of hyperopia and myopia, an increased elderly population, and increased adoption of telemedicine.

The amblyopia market size is expected to see steady growth in the next few years. It will grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to the rise of digital health platforms, increasing availability of resources and support for parents, growing emphasis on preventive healthcare for children, increasing awareness about amblyopia, and the proliferation of specialized eye care centers and clinics. Major trends in the forecast period include technological advancements in diagnostics, the development of new treatment modalities, advances in the understanding of visual development, discoveries in neuroplasticity, and the development and approval of new drugs.

The increasing incidence of ophthalmological diseases is expected to drive growth in the amblyopia market moving forward. Ophthalmological diseases encompass a spectrum of disorders affecting the eyes, ranging from common ailments such as cataracts and glaucoma to rarer conditions such as retinitis pigmentosa and ocular tumors. Factors contributing to the rise in these diseases include increased screen time, aging populations, and environmental factors such as pollution. Amblyopia, in particular, can exacerbate ophthalmological conditions by causing the brain to disregard input from the weaker eye, potentially leading to permanent vision impairment and issues with depth perception if left untreated. According to the Centers for Disease Control and Prevention (CDC), over 3.4 million Americans aged 40 years and older were blind or visually impaired in January 2024, a number expected to double by 2030. Therefore, the escalating prevalence of ophthalmological diseases is a key driver behind the growth of the amblyopia market.

Leading companies in the amblyopia market are focusing on technological innovations like active peripheral stimulation (APS) to enhance peripheral vision therapy. APS is a therapeutic approach that stimulates peripheral nerves or tissues to activate sensory pathways, offering potential benefits for pain relief, rehabilitation, and neurological conditions. For example, in October 2024, AmblyoPlay, a US-based startup specializing in digital vision therapy, introduced APS to improve treatment for peripheral vision deficiencies. This cutting-edge technique targets conditions like amblyopia (lazy eye), strabismus, and convergence insufficiency, which impact spatial awareness and overall visual function. By stimulating peripheral vision, APS addresses a public health concern affecting up to 5% of the global population. AmblyoPlay has incorporated APS into a gamified platform, making vision therapy more engaging and enjoyable, especially for children, while promoting better adherence to treatment.

In October 2022, Sumitomo Corporation, a Japan-based electrical services company, partnered with Juntendo University to develop a virtual reality (VR) app for amblyopia treatment. This app aims to enhance treatment engagement and efficacy by making therapy more interactive and enjoyable for children. Juntendo University, a prominent private university in Japan, is collaborating to leverage VR technology in optimizing amblyopia treatment protocols.

Major companies operating in the amblyopia market are Novartis AG, Takeda Pharmaceutical Company Limited, Biocon Limited, Astellas Pharma Inc., Alcon Vision LLC, Bausch Health Companies Inc., HOYA Corp., UnityPoint Health, Integra LifeSciences, Wockhardt Ltd., Welch Allyn, Heidelberg Engineering Inc., Orbis International, Oculus Optikgerate GmbH, Ocutrx Vision Technologies LLC, AccuVision, Vivid Vision Inc., Fresnel Prism and Lens Co., RevitalVision, WOW Vision Therapy, Lancastle International Ltd., Novasight, Eyenovia Inc., Adaptica Srl, AmblyoPlay

North America was the largest region in the amblyopia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amblyopia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the amblyopia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The amblyopia market consists of revenues earned by entities by providing services such as screening and diagnosis, vision therapy, patching therapy, and orthoptic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The amblyopia market also includes sales of contact lenses, vision therapy software, lighting products, bangerter filters, and spectacle lenses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Amblyopia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on amblyopia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for amblyopia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The amblyopia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease Type: Strabismus Amblyopia; Refractive Amblyopia; Deprivation Amblyopia; Reverse Amblyopia
  • 2) By Diagnosis: Visual Acuity Tests; Photo Screening; Bruckner Test; Other Diagnosis
  • 3) By Treatment: Eye Patches; Atropine Drops; Glasses; Video Games; Other Treatments
  • 4) By End User: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
  • Subsegments:
  • 1) By Strabismus Amblyopia: Congenital Strabismus Amblyopia; Acquired Strabismus Amblyopia; Non-Paralytic Strabismus Amblyopia; Paralytic Strabismus Amblyopia; Treatment For Misaligned Eyes (Eye Patches, Vision Therapy)
  • 2) By Refractive Amblyopia: Myopic Refractive Amblyopia; Hypermetropic Refractive Amblyopia; Astigmatic Refractive Amblyopia; Treatment Through Corrective Lenses (Glasses, Contact Lenses)
  • 3) By Deprivation Amblyopia: Amblyopia Due To Cataracts; Amblyopia Caused By Ptosis (Drooping Eyelid); Amblyopia From Corneal Opacities; Treatment Through Surgical Interventions Or Patching
  • 4) By Reverse Amblyopia: Amblyopia Due To Optic Nerve Dysfunction; Amblyopia Associated With Anisometropia (Unequal Refractive Errors); Treatment Through Vision Training Or Optical Correction
  • Companies Mentioned: Novartis AG; Takeda Pharmaceutical Company Limited; Biocon Limited; Astellas Pharma Inc.; Alcon Vision LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Amblyopia Market Characteristics

3. Amblyopia Market Trends And Strategies

4. Amblyopia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Amblyopia Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Amblyopia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Amblyopia Market Growth Rate Analysis
  • 5.4. Global Amblyopia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Amblyopia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Amblyopia Total Addressable Market (TAM)

6. Amblyopia Market Segmentation

  • 6.1. Global Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Strabismus Amblyopia
  • Refractive Amblyopia
  • Deprivation Amblyopia
  • Reverse Amblyopia
  • 6.2. Global Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Visual Acuity Tests
  • Photo Screening
  • Bruckner Test
  • Other Diagnosis
  • 6.3. Global Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Eye Patches
  • Atropine Drops
  • Glasses
  • Video Games
  • Other Treatments
  • 6.4. Global Amblyopia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • 6.5. Global Amblyopia Market, Sub-Segmentation Of Strabismus Amblyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Congenital Strabismus Amblyopia
  • Acquired Strabismus Amblyopia
  • Non-Paralytic Strabismus Amblyopia
  • Paralytic Strabismus Amblyopia
  • Treatment For Misaligned Eyes (Eye Patches, Vision Therapy)
  • 6.6. Global Amblyopia Market, Sub-Segmentation Of Refractive Amblyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Myopic Refractive Amblyopia
  • Hypermetropic Refractive Amblyopia
  • Astigmatic Refractive Amblyopia
  • Treatment Through Corrective Lenses (Glasses, Contact Lenses)
  • 6.7. Global Amblyopia Market, Sub-Segmentation Of Deprivation Amblyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amblyopia Due To Cataracts
  • Amblyopia Caused By Ptosis (Drooping Eyelid)
  • Amblyopia From Corneal Opacities
  • Treatment Through Surgical Interventions Or Patching
  • 6.8. Global Amblyopia Market, Sub-Segmentation Of Reverse Amblyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amblyopia Due To Optic Nerve Dysfunction
  • Amblyopia Associated With Anisometropia (Unequal Refractive Errors)
  • Treatment Through Vision Training Or Optical Correction

7. Amblyopia Market Regional And Country Analysis

  • 7.1. Global Amblyopia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Amblyopia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Amblyopia Market

  • 8.1. Asia-Pacific Amblyopia Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Amblyopia Market

  • 9.1. China Amblyopia Market Overview
  • 9.2. China Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Amblyopia Market

  • 10.1. India Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Amblyopia Market

  • 11.1. Japan Amblyopia Market Overview
  • 11.2. Japan Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Amblyopia Market

  • 12.1. Australia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Amblyopia Market

  • 13.1. Indonesia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Amblyopia Market

  • 14.1. South Korea Amblyopia Market Overview
  • 14.2. South Korea Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Amblyopia Market

  • 15.1. Western Europe Amblyopia Market Overview
  • 15.2. Western Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Amblyopia Market

  • 16.1. UK Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Amblyopia Market

  • 17.1. Germany Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Amblyopia Market

  • 18.1. France Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Amblyopia Market

  • 19.1. Italy Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Amblyopia Market

  • 20.1. Spain Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Amblyopia Market

  • 21.1. Eastern Europe Amblyopia Market Overview
  • 21.2. Eastern Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Amblyopia Market

  • 22.1. Russia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Amblyopia Market

  • 23.1. North America Amblyopia Market Overview
  • 23.2. North America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Amblyopia Market

  • 24.1. USA Amblyopia Market Overview
  • 24.2. USA Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Amblyopia Market

  • 25.1. Canada Amblyopia Market Overview
  • 25.2. Canada Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Amblyopia Market

  • 26.1. South America Amblyopia Market Overview
  • 26.2. South America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Amblyopia Market

  • 27.1. Brazil Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Amblyopia Market

  • 28.1. Middle East Amblyopia Market Overview
  • 28.2. Middle East Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Amblyopia Market

  • 29.1. Africa Amblyopia Market Overview
  • 29.2. Africa Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Amblyopia Market Competitive Landscape And Company Profiles

  • 30.1. Amblyopia Market Competitive Landscape
  • 30.2. Amblyopia Market Company Profiles
    • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biocon Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Alcon Vision LLC Overview, Products and Services, Strategy and Financial Analysis

31. Amblyopia Market Other Major And Innovative Companies

  • 31.1. Bausch Health Companies Inc.
  • 31.2. HOYA Corp.
  • 31.3. UnityPoint Health
  • 31.4. Integra LifeSciences
  • 31.5. Wockhardt Ltd.
  • 31.6. Welch Allyn
  • 31.7. Heidelberg Engineering Inc.
  • 31.8. Orbis International
  • 31.9. Oculus Optikgerate GmbH
  • 31.10. Ocutrx Vision Technologies LLC
  • 31.11. AccuVision
  • 31.12. Vivid Vision Inc.
  • 31.13. Fresnel Prism and Lens Co.
  • 31.14. RevitalVision
  • 31.15. WOW Vision Therapy

32. Global Amblyopia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Amblyopia Market

34. Recent Developments In The Amblyopia Market

35. Amblyopia Market High Potential Countries, Segments and Strategies

  • 35.1 Amblyopia Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Amblyopia Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Amblyopia Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer